Retrospective trial to study the efficacy of omalizumab in patients with elevated baseline IgE

Trial Profile

Retrospective trial to study the efficacy of omalizumab in patients with elevated baseline IgE

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Mar 2016

At a glance

  • Drugs Omalizumab (Primary)
  • Indications Allergic asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Mar 2016 New trial record
    • 07 Mar 2016 Results presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top